Investment Premium

A new approach to venture investing targeted at family offices

by

Mira Life Science Ventures is pitching for long-term backing from family offices using a fee structure which remunerates its team through dividend payments, as opposed to a 20% performance fee […]

This is a Premium article. Please subscribe to continue reading.

Leave a Reply

Your email address will not be published. Required fields are marked *